Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zierath, J. R.
Right arrow Articles by Kahn, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zierath, J. R.
Right arrow Articles by Kahn, B. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 1 1-4, Copyright © 1998 by American Diabetes Association


ARTICLES

Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes

JR Zierath, EU Frevert, JW Ryder, PO Berggren and BB Kahn
Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden. jrz@klinfys.ks.se

Recently, it has been proposed that leptin, the ob gene product, influences some steps in the insulin-signaling cascade. The purpose of the present study was to determine whether leptin exerts direct effects on glucose transport in insulin target tissues. Epitrochlearis muscles or isolated adipocytes from male SD rats were incubated in the absence or presence of recombinant leptin (3-1,000 ng/ml), and in the absence or presence of submaximal or maximal insulin concentrations. In skeletal muscle, insulin increased 3-O-methylglucose transport (1.88 +/- 0.21, 4.06 +/- 0.59, and 9.35 +/- 1.90 micromol x ml-1 x h-1, for 0, 0.6, and 12.0 nmol/l insulin, respectively). Leptin exposure (300 ng/ml) for 2 h did not alter the basal, submaximal, or maximal response of glucose transport to insulin in skeletal muscle (1.50 +/- 0.14, 4.76 +/- 0.58, and 9.04 +/- 1.09 micromol x ml-1 x h-1 for 0, 0.6, and 12.0 nmol/l insulin, respectively). Insulin increased glucose transport in rat adipocytes (0.194 +/- 0.007, 1.059 +/- 0.029, and 3.367 +/- 0.143 pmol [14C]glucose x 0.5 ml-1 cell suspension x min-1 for 0, 0.8, and 80 nmol/l insulin, respectively); in vitro exposure to leptin (300 ng/ml) did not alter glucose transport (0.220 +/- 0.006, 1.269 +/- 0.046, and 3.221 +/- 0.285 pmol [14C]glucose x 0.5 ml-1 cell suspension x min-1 for 0, 0.8, and 80 nmol/l insulin, respectively). Similar to our findings in the epitrochlearis muscle, leptin had no direct effect on basal or insulin-stimulated glucose uptake in soleus muscle from ob/ob or lean mice or adipocytes from normal mice. In summary, in vitro exposure of skeletal muscle or adipocytes to recombinant leptin did not alter glucose transport in the absence of insulin, nor did it affect the sensitivity or responsiveness of the glucose transport system to insulin.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Bays, L. Mandarino, and R. A. DeFronzo
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478.
[Full Text] [PDF]


Home page
DiabetesHome page
C. Perez, C. Fernandez-Galaz, T. Fernandez-Agullo, C. Arribas, A. Andres, M. Ros, and J. M. Carrascosa
Leptin Impairs Insulin Signaling in Rat Adipocytes
Diabetes, February 1, 2004; 53(2): 347 - 353.
[Abstract] [Full Text]


Home page
Recent Prog Horm ResHome page
C. Bjorbaek and B. B. Kahn
Leptin Signaling in the Central Nervous System and the Periphery
Recent Prog. Horm. Res., January 1, 2004; 59(1): 305 - 331.
[Abstract] [Full Text]


Home page
DiabetesHome page
A. Minami, M. Iseki, K. Kishi, M. Wang, M. Ogura, N. Furukawa, S. Hayashi, M. Yamada, T. Obata, Y. Takeshita, et al.
Increased Insulin Sensitivity and Hypoinsulinemia in APS Knockout Mice
Diabetes, November 1, 2003; 52(11): 2657 - 2665.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. B. CEDDIA, H. A. KOISTINEN, J. R. ZIERATH, and G. SWEENEY
Analysis of paradoxical observations on the association between leptin and insulin resistance
FASEB J, August 1, 2002; 16(10): 1163 - 1176.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Sweeney, J. Keen, R. Somwar, D. Konrad, R. Garg, and A. Klip
High Leptin Levels Acutely Inhibit Insulin-Stimulated Glucose Uptake without Affecting Glucose Transporter 4 Translocation in L6 Rat Skeletal Muscle Cells
Endocrinology, November 1, 2001; 142(11): 4806 - 4812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Lau, W. D. Blinn, A. Bonen, and D. J. Dyck
Stimulatory effects of leptin and muscle contraction on fatty acid metabolism are not additive
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E122 - E129.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. O’Rourke, S. J. Yeaman, and P. R. Shepherd
Insulin and Leptin Acutely Regulate Cholesterol Ester Metabolism in Macrophages by Novel Signaling Pathways
Diabetes, May 1, 2001; 50(5): 955 - 961.
[Abstract] [Full Text]


Home page
DiabetesHome page
T. J. Kowalski, S.-M. Liu, R. L. Leibel, and S. C. Chua Jr.
Transgenic Complementation of Leptin-Receptor Deficiency: I. Rescue of the Obesity/Diabetes Phenotype of LEPR-Null Mice Expressing a LEPR-B Transgene
Diabetes, February 1, 2001; 50(2): 425 - 435.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. R. Steinberg and D. J. Dyck
Development of leptin resistance in rat soleus muscle in response to high-fat diets
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1374 - E1382.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J.-Y. Kim, L. A. Nolte, P. A. Hansen, D.-H. Han, K. Ferguson, P. A. Thompson, and J. O. Holloszy
High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2057 - R2065.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y.-B. Kim, S. Uotani, D. D. Pierroz, J. S. Flier, and B. B. Kahn
In Vivo Administration of Leptin Activates Signal Transduction Directly in Insulin-Sensitive Tissues: Overlapping but Distinct Pathways from Insulin
Endocrinology, July 1, 2000; 141(7): 2328 - 2339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Nawano, A. Oku, K. Ueta, I. Umebayashi, T. Ishirahara, K. Arakawa, A. Saito, M. Anai, M. Kikuchi, and T. Asano
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E535 - E543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Bryson, J. L. Phuyal, V. Swan, and I. D. Caterson
Leptin has acute effects on glucose and lipid metabolism in both lean and gold thioglucose-obese mice
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E417 - E422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. M. O'Doherty, P. R. Anderson, A. Z. Zhao, K. E. Bornfeldt, and C. B. Newgard
Sparing effect of leptin on liver glycogen stores in rats during the fed-to-fasted transition
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E544 - E550.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Rouru, I. Cusin, K. E. Zakrzewska, B. Jeanrenaud, and F. Rohner-Jeanrenaud
Effects of Intravenously Infused Leptin on Insulin Sensitivity and on the Expression of Uncoupling Proteins in Brown Adipose Tissue
Endocrinology, August 1, 1999; 140(8): 3688 - 3692.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Barzilai, L. She, L. Liu, J. Wang, M. Hu, P. Vuguin, and L. Rossetti
Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E291 - E298.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. H. Zhang, S. Kumar, A. H. Barnett, and M. C. Eggo
Intrinsic Site-Specific Differences in the Expression of Leptin in Human Adipocytes and Its Autocrine Effects on Glucose Uptake
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2550 - 2556.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J.-l. Wang, N. Chinookoswong, S. Scully, M. Qi, and Z.-Q. Shi
Differential Effects of Leptin in Regulation of Tissue Glucose Utilization in Vivo
Endocrinology, May 1, 1999; 140(5): 2117 - 2124.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Muoio, G. L. Dohm, E. B. Tapscott, and R. A. Coleman
Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice
Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E913 - E921.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F-X. Pi-Sunyer and B. Laferrère
Metabolic Abnormalities and the Role of Leptin in Human Obesity
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 3 - 7.
[Full Text]


Home page
FASEB J.Home page
G. H. Crist, B. Xu, K. F. Lanoue, and C. H. Lang
Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats
FASEB J, October 1, 1998; 12(13): 1301 - 1308.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.